EQS Group-Ad-hoc: Lonza Group AG / Key word(s): Agreement/Expansion Lonza and Moderna Announce Further Collaboration For Drug Substance Manufacturing of COVID-19 Vaccine Moderna in the Netherlands 02-Jun-2021 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 KR The issuer is.
CADILLAC — The Traverse Narcotics Team has released details regarding the case against a 30-year-old Traverse City man and a 34-year-old Traverse City woman who face potential life sentences for
Approval of BREXAFEMME represents the first approved drug in a novel antifungal class in more than 20 yearsBREXAFEMME, a one-day oral treatment for vaginal yeast infection, is the first. | June 2, 2021